Raynaud’s Phenomenon and Ulcers

Michael Hughes*, Marina E. Anderson, Ariane L. Herrick

*Corresponding author for this work

Research output: Chapter in Book/Conference proceedingChapterpeer-review

Abstract

Raynaud’s phenomenon (RP) is a common condition which can occur either primary (idiopathic) or secondary to a wide range of conditions or drug therapies. In patients with systemic sclerosis (SSc), RP occurs within a spectrum of digital vascular disease, including digital ulceration and ischaemia. In this chapter, we present the background (clinical features, epidemiology, pathogenesis and differential diagnosis) and clinical assessment including an approach to investigations (in particular nailfold capillaroscopy and SSc-associated antibodies) which clinicians need to be aware of when assessing with patients with RP. The multifaceted contemporary approach to the management of RP is presented, including pharmacological strategies, with examples of drug doses and a number of treatment algorithms for digital vascular disease (including RP) which are intended to provide the clinician with a useful reference tool.
Original languageEnglish
Title of host publicationAtlas of Ulcers in Systemic Sclerosis
Subtitle of host publicationDiagnosis and Management
EditorsMarco Matucci-Cerinic, Christopher P. Denton
Place of PublicationCham
PublisherSpringer Cham
Pages45–62
Number of pages18
ISBN (Electronic)9783319984773
ISBN (Print)9783319984759
DOIs
Publication statusPublished - 13 Nov 2018

Keywords

  • Raynaud’s phenomenon
  • digital ulcer
  • systemic sclerosis
  • scleroderma
  • management
  • treatment
  • non-drug therapies
  • drug therapies
  • capillaroscopy
  • thermography

Fingerprint

Dive into the research topics of 'Raynaud’s Phenomenon and Ulcers'. Together they form a unique fingerprint.

Cite this